On The Line: What Canadian digital sovereignty?
About this episode
The episode discusses the concept of digital sovereignty in Canadian public policy with insights from James McLeod.
In this episode of On The Line , host Jen Gerson sits down with James McLeod of the Canadian Shield Institute to discuss one of the most talked-about — and least understood — concepts in Canadian public policy: digital sovereignty. This episode of On The Line is brought to you by BioCanRX. Nearly half of all Canadians will get a cancer diagnosis in their lives. Canadian scientists are moving fast to come up with better treatments to help these people. But it’s not just about science, it’s about the logistics of implementing it. BioCanRx is a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Since launching in 2015, they’ve funded 16 clinical trials and treated more than 400 patients across Canada, all with made-in-Canada technologies. What is immunotherapy? Most immune systems successfully eliminate threats every day — including our own cells when they mutate in ways they shouldn’t. But when our mutating cells find a way to trick our immune systems, things can start getting out of control. That’s usually when we apply the label “cancer.”…
Sponsors
BioCanRX
More episodes of The Line Podcast
- The Line Podcast: Canada and America, a (gross) love story
- On The Line: Beware angry Quebec voters, and, rogue AIs
- The Line Podcast: Canadians secretly love Mark Carney BECAUSE he yells
- The Line Podcast: Carney is winning the vibes war
- On The Line: When Trump is gone, will we still want a bigger military?
- The Line Podcast: Alberta wakes up, chooses chaos, drags 35 million Canadians along
Explore listener stats, chart rankings, contacts and more on the The Line Podcast podcast page.